Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue 8, 2009, Pages 662-671

  Erez, Offer ^a,b   Romero, Roberto ^a,b   Vaisbuch, Edi ^a,b   Mazaki Tovi, Shali ^a,b   Kusanovic, Juan Pedro ^a,b   Chaiworapongsa, Tinnakorn ^a,b   Than, Nandor Gabor ^a   Gotsch, Francesca ^a   Kim, Chong Jai ^a,b   Mittal, Pooja ^a,b   Edwin, Samuel ^a   Pacora, Percy ^a   Kim, Sun Kwon ^a   Yeo, Lami ^a,b   Mazor, Moshe ^c   Hassan, Sonia S ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antiphospholipid; Autoantibodies; Hypertension; Placenta; Pregnancy; Vasculitis protein Z

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTERITIS; ARTERY; ARTICLE; BASAL PLATE ARTERY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS DEATH; HUMAN; MAJOR CLINICAL STUDY; MATERNAL PLASMA; PHLEBITIS; PLACENTA VILLUS; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCTION; SMALL FOR DATE INFANT; THROMBOSIS; UMBILICAL ARTERY; UMBILICAL VEIN; VASCULAR LESION;

ADULT; AUTOANTIBODIES; BLOOD PROTEINS; CROSS-SECTIONAL STUDIES; FEMALE; FETAL DEATH; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; VASCULAR DISEASES;

EID: 70350666477     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050902801751     Document Type: Article

References (76)

1. Rezaie AR, Manithody C, Yang L. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition. J Biol Chem 2005;280:32722-32728.
2. Yin ZF, Huang ZF, Cui J, Fiehler R, Lasky N, Ginsburg D, Broze GJ, Jr. et al. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci USA 2000;97:6734-6738.
3. Han X, Fiehler R, Broze GJ Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA 1998;95:9250-9255.
4. Han X, Huang ZF, Fiehler R, Broze GJ, Jr. The protein Z-dependent protease inhibitor is a serpin. Biochemistry 1999;38:11073-11078.
5. Han X, Fiehler R, Broze GJ, Jr. Characterization of the protein Z-dependent protease inhibitor. Blood 2000;96:3049-3055.
6. Quack Loetscher KC, Stiller R, Roos M, Zimmermann R. Protein Z in normal pregnancy. Thromb Haemost 2005;93: 706-709.
7. Paidas MJ, Ku DH, Lee MJ, Manish S, Thurston A, Lockwood CJ, Arkel YS. Protein Z. Protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. J Thromb Haemost 2005;3:497-501.
8. Erez O, Hoppensteadt D, Romero R, Espinoza J, Goncalves L, Nien JK, Kusanovic JP, Fareed J, Gotsch F, Pineles B, et al. Pre-eclampsia is associated with low concentrations of protein Z. J Matern Fetal Neonatal Med 2007;20:661-667.
9. Kusanovic JP, Espinoza J, Romero R, Hoppensteadt D, Nien JK, Kim CJ, Kim CJ, Erez O, Soto E, Fareed J, Edwin S, et al. Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor. J Matern Fetal Neonatal Med 2007;20: 453-463.
10. Gris JC, Quere I, Dechaud H, Mercier E, Pincon C, Hoffet M, Vasse M, Mares P. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002;99: 2606-2608.
11. Bretelle F, Arnoux D, Shojai R, D'Ercole C, Sampol J, Dignat F, Camoin-Jau L. Protein Z in patients with pregnancy complications. Am J Obstet Gynecol 2005;193:1698-1702.
12. Paidas MJ, Ku DH, Arkel YS, Elizabeth T, Christine F, Ben H, Ku Evelyn, Lockwood CJ. Normal pregnancy is associated with the development of protein S and protein Z antibodies, independent of PS and PZ levels. Am J Obstet Gynecol 2004;6 (Supp.1):s140.
13. Gris JC, Amadio C, Mercier E, Lavigne-Lissalde G, Dechaud H, Hoffet M, Quere I, Amiral J, Dauzat M, Mares P. Antiprotein Z antibodies in women with pathologic pregnancies. Blood 2003;101:4850-4852.
14. Gris JC, Mercier E, Quere I, Lavigne-Lissalde G, Cochery- Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland ML, Dauzat M, Mares P. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103: 3695-3699.
15. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159-167.
16. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996;87:163-168.
17. Redline RW, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation - a workshop report. Placenta 2005;26 (Suppl A):S114-S117.
18. Steffano B, Forastiero R, Martinuzzo M, Kordich L. Low plasma protein Z levels in patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 2001;12:411-412.
19. McColl MD, Deans A, Maclean P, Tait RC, Greer IA, Walker ID. Plasma protein Z deficiency is common in women with antiphospholipid antibodies. Br J Haematol 2003;120:913-914.
20. Forastiero RR, Martinuzzo ME, Lu L, Broze GJ. Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor. J Thromb Haemost 2003;1:1764-1770.
21. Shoenfeld Y, Blank M. Autoantibodies associated with reproductive failure. Lupus 2004;13:643-648.
22. Pardos-Gea J, Ordi-Ros J, Serrano S, Balada E, Nicolau I, Vilardell M. Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis. Thromb Res 2007;121:727-734.
23. Sailer T, Vormittag R, Koder S, Quehenberger P, Kaider A, Pabinger I. Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant. Thromb Res 2008;122(2): 153-160.
24. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol. Today 1991;12:154-159.
25. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995;7:812-818.
26. Boyden SV. Natural antibodies and the immune response. Adv Immunol 1966;5:1-28.
27. Navin TR, Krug EC, Pearson RD. Effect of immunoglobulin M from normal human serum on Leishmania donovani promastigote agglutination, complement-mediated killing, and phagocytosis by human monocytes. Infect Immun 1989;57:1343-1346.
28. Elson CJ, Naysmith JD, Taylor RB. B-cell tolerance and autoimmunity. Int Rev Exp Pathol 1979;19:137-203.
29. Michael JG. Natural antibodies. Curr Top Microbiol Immunol 1969;48:43-62.
30. Kay MM, Goodman SR, Sorensen K, Whitfield CF, Wong P, Zaki L, Rudloff V. Senescent cell antigen is immunologically related to band 3. Proc Natl Acad Sci USA 1983;80:1631-1635.
31. Galili U, Clark MR, Shohet SB. Excessive binding of natural anti-a-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest 1986;77:27-33.
32. Hintner H, Romani N, Stanzl U, Grubauer G, Fritsch P, Lawley TJ. Phagocytosis of keratin filament aggregates following opsonization with IgG-anti-keratin filament autoantibodies. J Invest Dermatol 1987;88:176-182.
33. Lutz HU, Bussolino F, Flepp R, Fasler S, Stammler P, Kazatchkine MD, Arese P. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc Natl Acad Sci USA 1987;84:7368-7372.
34. Grabar P. Hypothesis. Auto-antibodies and immunological theories: an analytical review. Clin Immunol Immunopathol 1975;4:453-466.
35. Mold C, Rodic-Polic B, Du Clos TW. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcg receptors. J Immunol 2002;168:6375-6381.
36. Shaw PX, Horkko S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, Witztum JL. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000;105:1731-1740.
37. Quan CP, Berneman A, Pires R, Avrameas S, Bouvet JP. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 1997;65:3997-4004.
38. Lacroix-Desmazes S, Kaveri SV, Mouthon L, Ayouba A, Malanchere E, Coutinho A, Kazatchkine MD. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods 1998;216:117-137.
39. el-Roeiy A, Myers SA, Gleicher N. The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstet Gynecol 1990;75:390-396.
40. Matthiesen LS, Berg G, Ernerudh J, Skogh T. A prospective study on the occurrence of autoantibodies in low-risk pregnancies. Eur J Obstet Gynecol Reprod Biol 1999;83:21-26.
41. Farnam J, Lavastida MT, Grant JA, Reddi RC, Daniels JC. Antinuclear antibodies in the serum of normal pregnant women: a prospective study. J Allergy Clin Immunol 1984;73:596-599.
42. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989;161:369-373.
43. Pattison NS, ChamleyLW,McKay EJ, Liggins GC, ButlerWS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993;100:909-913.
44. Patton PE, Coulam CB, Bergstralh E. The prevalence of autoantibodies in pregnant and nonpregnant women. Am J Obstet Gynecol 1987;157:1345-1350.
45. Wootla B, Dasgupta S, Dimitrov JD, Bayry J, Levesque H, Borg JY, Borel-Derlon A, Rao DN, Friboulet A, Kaveri SV, et al. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia. J Immunol 2008; 180:7714-7720.
46. Allain JP, Croissant MP, Lerolle D, Houbouyan L, Zuzel M, Frommel D. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex. Thromb Haemost 1982;48: 142-145.
47. Croissant MP, Zuzel M, Allain JP. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein. Blood 1983;62:133-140.
48. Sultan Y, Rossi F, Kazatchkine MD. Recovery from anti- VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII: C autoantibodies. Proc Natl Acad Sci USA 1987;84:828-831.
49. Hart HC, Kraaijenhagen RJ, Kerckhaert JA, Verdel G, Freen M, van de WA. A patient with a spontaneous factor VIII: C autoantibody: successful treatment with cyclosporine. Transplant Proc 1988;20:323-328.
50. Algiman M, Dietrich G, Nydegger UE, Boieldieu D, Sultan Y, Kazatchkine MD. Natural antibodies to factor VIII (antihemophilic factor) in healthy individuals. Proc Natl Acad Sci USA 1992;89:3795-3799.
51. Dahlback B, Nilsson IM, Frohm B. Inhibition of platelet prothrombinase activity by a lupus anticoagulant. Blood 1983;62:218-225.
52. Fleck RA, Rapaport SI, Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988;72:512-519.
53. Horbach DA, Derksen RH, de Groot PG. The presence of anti-b 2-glycoprotein I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis. Ann Med Interne (Paris) 1996;147 (Suppl 1):42-43.
54. Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A. Anticardiolipin, anti-b(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol 1997;24:1710-1715.
55. Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO. Relationship of anti b2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 1997;78:1008-1014.
56. Bidot CJ, Jy W, Horstman LL, Huisheng H, Jimenez JJ, Yaniz M, Ahn YS. Factor VII/VIIa: a new antigen in the antiphospholipid antibody syndrome. Br J Haematol 2003;120: 618-626.
57. Ruiz-Arguelles GJ, Ruiz-Arguelles A, Perez-Romano B, Arcon-Segovia D. Protein S deficiency associated to antiprotein S antibodies in a patient with mixed connective-tissue disease and its reversal by danazol. Acta Haematol 1993;89: 206-208.
58. Sorice M, Arcieri P, Griggi T, Circella A, Misasi R, Lenti L, Di Nucci GD, Mariani G. Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency. Thromb Haemost 1996;75:555-559.
59. Erkan D, Zhang HW, Shriky RC, Merrill JT. Dual antibody reactivity to b2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome. Lupus 2002;11:215-220.
60. Bertolaccini ML, Sanna G, Ralhan S, Gennari LC, Merrill JT, Khamashta MA, Hughes GR. Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost 2003; 90:636-641.
61. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost 1997;77: 444-451.
62. Jones JV, Eastwood BJ, Jones E, James H, Mansour M. Antiphospholipid antibodies in a healthy population: methods for estimating the distribution. J Rheumatol 1995; 22:55-61.
63. Rand JH, Senzel L. Antiphospholipid antibodies and the antiphospholipid syndrome. In: Colman RW, Clowes AE, Goldhaber SZ, Marder VJ, George JN, editors. Hemostasis and thrombosis basic principles and clinical practice. Philadelphia: Lippincott Williames & Wilkins; 2006. pp 1621-1636.
64. Lieby P, Poindron V, Roussi S, Klein C, Knapp AM, Garaud JC, Cerutti M, Martin T, Pasquali JL. Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack. Blood 2004;104:1711-1715.
65. von Dadelszen P, Watson RW, Noorwali F, Marshall JC, Parodo J, Farine D, Lye SJ, Ritchie JW, Rotstein OD. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999;181:408-414.
66. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to pre-eclampsia. J Soc Gynecol Investig 2004;11:342-352.
67. Chaiworapongsa T, Yoshimatsu J, Espinoza J, Kim YM, Berman S, Edwin S, Yoon BH, Romero R. Evidence of in vivo generation of thrombin in patients with small-forgestational- age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med 2002;11:362-367.
68. Erez O, Romero R, Hoppensteadt D, Than NG, Fareed J, Mazaki-Tovi S, Espinoza J, Chaiworapongsa T, Kim SS, Yoon BH, et al. Tissue factor and its natural inhibitor in preeclampsia and SGA. Reprod Sci A 2007;182.
69. Dorner T, Hoppe B, Salama A, Pruss A, Kiesewetter H. Antibodies against protein Z and fetal loss: current perspectives. Clin Exp Med 2005;5:50-54.
70. Nordenvall M, Sandstedt B. Placental villitis and intrauterine growth retardation in a Swedish population. APMIS 1990; 98:19-24.
71. Becroft DM, Thompson JM, Mitchell EA. Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol 2005;192:264-271.
72. Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 2002;5:159-164.
73. Laurini R, Laurin J, Marsal K. Placental histology and fetal blood flow in intrauterine growth retardation. Acta Obstet Gynecol Scand 1994;73:529-534.
74. Althabe O, Labarrere C, Telenta M. Maternal vascular lesions in placentae of small-for-gestational-age infants. Placenta 1985;6:265-276.
75. Altshuler G, Russell P, Ermocilla R. The placental pathology of small-for-gestational age infants. Am J Obstet Gynecol 1975;121:351-359.
76. Becroft DM, Thompson JM, Mitchell EA. Placental infarcts, intervillous fibrin plaques, and intervillous thrombi: incidences, co-occurrences, and epidemiological associations. Pediatr Dev Pathol 2004;7:26-34.